Iterum Therapeutics Plc (ITRM) Company Profile & Statistics

Iterum Therapeutics Plc
ITRM
(Nasdaq - US)
N/A
1.55
-0.03 (-1.90%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
1.56
High
1.56
Low
1.55

About Iterum Therapeutics Plc

CEO

Corey N. Fishman

Headquarters

fitzwilliam court 1st floor,leeson close

dublin, l2 d02, ireland

Auditor

KPMG

Employees

Share Holders

Website

www.iterumtx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.

Iterum Therapeutics Plc Statistics

Valuation Measures

Market Capitalization ²	25.67M
Enterprise Value	31.05M
Enterprise Value/EBITDA (ttm)	-0.72
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-664.00%
Return on Invested Capital (ttm)	-367.47%
Return on Assets (ttm)	-87.64%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-43.38M
Net Income Avi to Common (ttm)	-38.37M
Diluted EPS (ttm)	-2.97

Share Statistics

Beta (5Y Monthly)	2.33
52-Week Change	37.17%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	16.43M
Dividend Yield	0.00%
Float ⁴	15.66M
% Held by Insiders	5.40%
% Held by Institutions	9.21%

Balance Sheet

Total Cash (mrq)	23.93M
Total Cash Per Share (mrq)	1.46
Total Debt (mrq)	11.45M
Total Debt/Equity (mrq)	-178.87%
Current Ratio (mrq)	1.89%
Quick Ratio (mrq)	1.89%
Book Value Per Share (mrq)	-0.47

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.03
Free Cash Flow (ytd)	-39.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Iterum Therapeutics Plc

Trade With A Regulated Broker